Company
Headquarters: Mentor, OH, United States
CEO: Mr. Walter M. Rosebrough Jr.
R$127.42 Billion
BRL as of Jan. 1, 2025
US$20.62 Billion
Company | Market Cap (USD) |
---|---|
Abbott | $213.72 B |
Stryker | $150.01 B |
Boston Scientific Corporation | $149.80 B |
Medtronic | $114.44 B |
Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
STERIS Corporation provides infection prevention and procedural products and services. The company offers surgical equipment and image management, sterile processing equipment, surgical sterilization and instrument, surgical instrument cleaning, endoscope devices, endoscope reprocessing, medical device repair, sterility assurance monitoring, and contract sterilization services, including gamma irradiation, electron beam irradiation, x-ray irradiation, and ethylene oxide sterilization. It also provides process cleaning detergents, surface disinfectants, cleaners, washing equipment, and sterilizers. STERIS Corporation was formerly known as Innovative Medical Technologies. The company was founded in 1985 and is based in Mentor, Ohio with additional locations worldwide. STERIS Corporation operates as a subsidiary of STERIS plc.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Last Financial Reports Date | Sept. 30, 2024 |
Revenue TTM | R$31.55 B |
EBITDA | R$1.43 B |
Gross Profit TTM | R$13.70 B |
Profit Margin | 8.16% |
Operating Margin | 16.98% |
Quarterly Revenue Growth | 7.30% |
STERIS Corp has the following listings and related stock indices.
Stock: Bovespa: S1TE34 wb_incandescent